- Home
- TTE vs BMY Comparison
TTE vs BMY Comparison
Compare TTE & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTE
- BMY
- Stock Information
- Founded
- TTE 1924
- BMY 1887
- Country
- TTE France
- BMY United States
- Employees
- TTE N/A
- BMY N/A
- Industry
- TTE Oil & Gas Production
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- TTE Energy
- BMY Health Care
- Exchange
- TTE Nasdaq
- BMY Nasdaq
- Market Cap
- TTE 143.5B
- BMY 120.5B
- IPO Year
- TTE 1991
- BMY N/A
- Fundamental
- Price
- TTE $58.46
- BMY $49.23
- Analyst Decision
- TTE Buy
- BMY Hold
- Analyst Count
- TTE 6
- BMY 15
- Target Price
- TTE $69.42
- BMY $57.79
- AVG Volume (30 Days)
- TTE 2.1M
- BMY 14.6M
- Earning Date
- TTE 04-30-2025
- BMY 04-24-2025
- Dividend Yield
- TTE 5.80%
- BMY 5.04%
- EPS Growth
- TTE N/A
- BMY N/A
- EPS
- TTE 6.69
- BMY N/A
- Revenue
- TTE $195,610,000,000.00
- BMY $48,300,000,000.00
- Revenue This Year
- TTE $11.63
- BMY N/A
- Revenue Next Year
- TTE N/A
- BMY N/A
- P/E Ratio
- TTE $8.29
- BMY N/A
- Revenue Growth
- TTE N/A
- BMY 7.32
- 52 Week Low
- TTE $52.78
- BMY $39.35
- 52 Week High
- TTE $74.97
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- TTE 46.43
- BMY 25.85
- Support Level
- TTE $52.78
- BMY $48.84
- Resistance Level
- TTE $57.36
- BMY $51.60
- Average True Range (ATR)
- TTE 1.81
- BMY 2.35
- MACD
- TTE -0.26
- BMY -0.84
- Stochastic Oscillator
- TTE 46.14
- BMY 3.20
About TTE TotalEnergies SE
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2023, it produced 1.6 million barrels of liquids and 5.0 billion cubic feet of natural gas per day. At end-2023, reserves stood at 10.6 billion barrels of oil equivalent, 56% of which are liquids. During 2023, it had LNG sales of 44.3 metric tons. The company owns interests in refineries with capacity of nearly 2.0 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. At year-end, its gross installed renewable power generation capacity was 22.4 gigawatts.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.